Crohn's disease: open trials in Spain

37 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2024-518296-56-00
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Area Sanitaria De Ferrol, Ferrol · Hospital Universitario Puerta de Hierro de Majadahonda, Madrid · Hospital Universitario La Paz, Madrid · Complexo Hospitalario Universitario de Pontevedra, Pontevedra · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Hospital Universitario de Torrejon, Torrejón de Ardoz · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-11-06
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Area Sanitaria De Ferrol, Ferrol · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Centro Médico Teknon, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide, Ferrol · Hospital de Cabuenes, Gijón · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Central De Asturias, Oviedo · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Virgen Macarena, Seville · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-11-04
NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Universitario Reina Sofia, Córdoba · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario de la Princesa, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hosp. Gral. Univ. Dr. Balmis, Alicante · Hosp Clinic de Barcelona, Barcelona · Hosp. Arquitecto Marcide, Ferrol · Hosp. de Cabuenes, Gijón · Hosp. Univ. Dr. Josep Trueta, Girona · Hosp. Univ. de Torrejon, Madrid · Hosp. de Navarra, Navarra · Hosp. Clinico Univ. de Santiago, Santiago de Compostela · Hosp. Virgen Macarena, Seville
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Area Sanitaria De Ferrol, Ferrol · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Complexo Hospitalario Universitario De Vigo, Vigo
Registry updated 2026-11-03
NCT07848737
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
Research · Janssen-Cilag, S.A.
Hosp. Clinico Univ. de Santiago, Santiago de Compostela
Registry updated 2026-11-03
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Area Sanitaria De Ferrol, Ferrol · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Madrid · Complexo Hospitalario Universitario de Pontevedra, Pontevedra · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Hospital Universitario de Torrejon, Torrejón de Ardoz · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-11-02
NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Trial Treatment · Phase 2 · Sanofi
Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitario La Paz, Madrid · Futuremeds Spain S.L., Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-02
2025-522362-78-00
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Trial Treatment · Phase 4 · Eli Lilly & Co.
Hospital Universitario La Paz, Madrid
Registry updated 2026-10-30
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Universitario Fundación Alcorcón, Alcorcón · Hospital Universitario de Fuenlabrada, Fuenlabrada · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Gijón · Huelva · Madrid · Ourense
Registry updated 2026-10-21
NCT05995353
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · AbbVie
Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Area Sanitaria De Ferrol, Ferrol · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Regional de Málaga, Málaga
Registry updated 2026-10-20
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Universitario Reina Sofia, Córdoba · Hospital de Galdakao-Usansolo, Galdakao · Hospital Universitario La Paz, Madrid · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Universitario Rio Hortega, Valladolid
Registry updated 2026-10-16
2026-525197-19-00
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
Trial Treatment · Phase 2 · Agomab Spain S.L.U.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario de Navarra, Pamplona · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-14
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Area Sanitaria De Ferrol, Ferrol · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-09
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario Reina Sofia, Córdoba · Hospital Sant Joan De Deu, Esplugues de Llobregat · Hospital Universitari Parc Taulí, Sabadell · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario Reina Sofia, Córdoba · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-07
NCT07795476
Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes
Research · PharmaNest, Inc
University Hospital Virgen del Rocio, Seville · University Hosptal Virgen Macarena, Seville
Registry updated 2026-10-01
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Hospital Universitario de Fuenlabrada, Fuenlabrada · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Alvaro Cunqueiro, Vigo
Registry updated 2026-09-25
2025-521590-13-00
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Trial Treatment · Phase 3 · Janssen Cilag International
Hospital General Universitario Dr. Balmis, Alicante · Hospital Clinic de Barcelona, Barcelona · Area Sanitaria De Ferrol, Ferrol · Hospital Universitario de Cabueñes, Gijón · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario de Navarra, Pamplona · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario de Torrejon, Torrejón de Ardoz
Registry updated 2026-08-28
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Area Sanitaria De Ferrol, Ferrol · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-08-03
NCT07316621
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
Research · GLSMED Learning Health S.A.
Hospital Galdakao-Usansolo, Galdakao
Registry updated 2026-07-29

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error